Industry: Custom services and reagents
GlycArray’s proprietary technology was developed by researchers at the Emory Glycomics Center. The company’s main focus is providing products and services to research institutions to aid in their work on glycomics, a major avenue for identifying new drug targets.
Glycomics is the study of sugars, which are essential to many physiological processes and are often influential in many diseases. GlycArray’s products and services will better enable researchers to analyze the structures of complex carbohydrates and determine their therapeutic potential.
The market for basic drug discovery research is more than $20 billion annually. With glycomics representing an increasingly significant subset of this research, the market opportunity for glycomics-oriented drug discovery tools is expected to grow.